Department of Urology, UC San Diego Health, San Diego, California, USA.
School of Medicine, UC San Diego, La Jolla, California, USA.
J Endourol. 2022 Nov;36(11):1418-1424. doi: 10.1089/end.2021.0811.
For treatment of nephrolithiasis, ambulatory percutaneous nephrolithotomy (aPCNL) is growing in popularity for select patients. The aim of this study was to investigate the safety and efficacy of a set of aPCNL selection criteria as well as search for predictors of failed aPCNL resulting in inpatient admission. We reviewed all percutaneous nephrolithotomy (PCNL) patients from 2016 to 2020. A total of 175 met selection criteria for aPCNL and were included. Primary outcome was safety and efficacy, and secondary outcome was to identify predictors of inpatient stay. Demographic and perioperative data were analyzed with both descriptive and inferential statistics. In total, between 2016 and 2020, 552 patients underwent PCNL, with 175 of them meeting criteria for aPCNL. One hundred thirty-four of the 175 (76.6%) of these patients were discharged the same day as the surgery and 41 patients were admitted. On univariate analysis, patients who required upper pole access or multiple accesses ( = 0.038) American Society of Anesthesiologists >2 ( = 0.005), or postoperative nephrostomy (PCN) tube ( < 0.001) were more likely to be admitted after surgery. On multivariate analysis, only postoperative PCN was significantly associated with admission ( = 0.015). Regarding reasons for unsuccessful aPCNL, 19.5% of admissions were attributed to intraoperative complications, 7% to social causes, 12.2% to postoperative complications, 14.6% to uncontrolled pain, and 34.1% to unexpected intraoperative procedures. aPCNL using selection criteria is safe and effective, with postoperative PCN predicting the possible necessity for conversion to inpatient admission. Furthermore, our study provides a practical algorithm for those opting to provide aPCNL to patients.
对于肾结石的治疗,经皮肾镜碎石术(PCNL)在一些患者中越来越受欢迎。本研究旨在探讨一套 PCNL 选择标准的安全性和有效性,并寻找导致住院的失败经皮肾镜碎石术(PCNL)的预测因素。我们回顾了 2016 年至 2020 年所有接受 PCNL 的患者。共有 175 名患者符合 PCNL 选择标准,并被纳入研究。主要结局是安全性和有效性,次要结局是确定住院的预测因素。采用描述性和推断性统计方法分析人口统计学和围手术期数据。
在 2016 年至 2020 年期间,共有 552 名患者接受了 PCNL,其中 175 名患者符合 aPCNL 标准。175 名患者中有 134 名(76.6%)在手术当天出院,41 名患者入院。在单因素分析中,需要上极入路或多入路(=0.038)、美国麻醉医师协会(ASA)评分>2(=0.005)或术后肾造瘘管(PCN)(<0.001)的患者术后更有可能住院。多因素分析显示,只有术后 PCN 与住院显著相关(=0.015)。
关于 aPCNL 失败的原因,19.5%的住院患者归因于术中并发症,7%归因于社会原因,12.2%归因于术后并发症,14.6%归因于疼痛无法控制,34.1%归因于术中意外程序。
使用选择标准的 aPCNL 是安全有效的,术后 PCN 预测可能需要转为住院治疗。此外,我们的研究为那些选择为患者提供 aPCNL 的人提供了一个实用的算法。